Bausch Health Cos., Inc. (BHC.TO)
9.23
+0.41
(+4.65%)
CAD |
TSX |
Aug 24, 16:00
Bausch Health Cos. Price : 9.23 for Aug. 24, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 24, 2026 | 8.93 | 9.28 | 8.89 | 9.23 | 676804.0 |
| Aug 21, 2026 | 9.42 | 9.45 | 8.77 | 8.82 | 2.484M |
| Aug 20, 2026 | 9.37 | 9.52 | 9.19 | 9.41 | 400700.0 |
| Aug 19, 2026 | 9.63 | 9.76 | 9.26 | 9.48 | 571689.0 |
| Aug 18, 2026 | 9.09 | 9.76 | 9.09 | 9.65 | 839278.0 |
| Aug 17, 2026 | 8.99 | 9.13 | 8.73 | 9.11 | 582302.0 |
| Aug 14, 2026 | 8.70 | 9.05 | 8.57 | 9.02 | 744991.0 |
| Aug 13, 2026 | 8.71 | 8.92 | 8.64 | 8.83 | 986282.0 |
| Aug 12, 2026 | 8.57 | 8.705 | 8.425 | 8.62 | 892546.0 |
| Aug 11, 2026 | 8.80 | 8.81 | 8.59 | 8.68 | 405660.0 |
| Aug 10, 2026 | 8.70 | 9.10 | 8.70 | 8.83 | 506573.0 |
| Aug 07, 2026 | 8.23 | 8.73 | 8.22 | 8.70 | 457320.0 |
| Aug 06, 2026 | 8.75 | 8.85 | 8.24 | 8.28 | 1.029M |
| Aug 05, 2026 | 9.12 | 9.12 | 8.61 | 8.80 | 620608.0 |
| Aug 04, 2026 | 9.76 | 9.93 | 8.94 | 9.07 | 1.538M |
| Jul 31, 2026 | 8.39 | 9.69 | 8.39 | 9.65 | 2.061M |
| Jul 30, 2026 | 6.96 | 8.495 | 6.96 | 8.43 | 3.384M |
| Jul 29, 2026 | 6.37 | 6.59 | 6.31 | 6.56 | 713739.0 |
| Jul 28, 2026 | 6.43 | 6.49 | 6.32 | 6.40 | 377080.0 |
| Jul 27, 2026 | 6.35 | 6.485 | 6.32 | 6.34 | 357111.0 |
| Jul 24, 2026 | 6.28 | 6.33 | 6.22 | 6.25 | 290401.0 |
| Jul 23, 2026 | 6.43 | 6.43 | 6.25 | 6.28 | 344007.0 |
| Jul 22, 2026 | 6.32 | 6.62 | 6.32 | 6.44 | 512669.0 |
| Jul 21, 2026 | 6.59 | 6.615 | 6.10 | 6.38 | 851336.0 |
| Jul 20, 2026 | 6.80 | 6.80 | 6.595 | 6.61 | 431203.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| HLS Therapeutics, Inc. | 3.69 |
| Cipher Pharmaceuticals, Inc. | 14.10 |
| BioSyent, Inc. | 15.50 |
| Revive Therapeutics Ltd. | 0.025 |
| Knight Therapeutics, Inc. | 9.66 |
Price Related Metrics
| PS Ratio | 0.2303 |
| Price to Free Cash Flow | 1.802 |
| Earnings Yield | -43.95% |
| Market Cap | 3.451B |
| Operating PE Ratio | 0.9144 |
| Normalized PE Ratio | 12.08 |